内毒素 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
Lyophilized material is typically held under refrigeration between two and eight degrees Celsius, shielded from light and ambient moisture. Peptides of this size adsorb to glass and plastic, so working procedures often call for low-binding containers and as few transfers as possible. Absorbed water during weighing shifts the apparent mass of a sample, and controlling room humidity reduces that source of error. Once dissolved, solutions are kept cold and used within the interval printed on the accompanying label or certificate. Degradation accelerates markedly in dilute aqueous form.
Identity and purity are judged through a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact peptide from truncated, oxidized, and deamidated variants, and the resulting peak-area percentages yield a purity figure. Electrospray ionization mass spectrometry confirms the expected molecular mass and can expose unanticipated modifications. Amino acid analysis and peptide mapping support sequence fidelity, while water content, pH, sterility, and bacterial endotoxin testing describe the physical and microbiological attributes of a finished lot.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C221H366N72O67S | Reflects a 44-residue peptide with one N-terminal modification |
| Approximate molecular weight | 5136 Da | Sequence length and single acyl group determine the mass |
| Appearance | White to off-white lyophilized powder | Typical form of a purified synthetic peptide |
| Solubility class | Soluble in water and aqueous buffer | Peptide backbone favors aqueous dissolution |
| Common synonyms | GHRH(1-44) analogue; Egrifta | Descriptive name and approved brand name |
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
纯度与身份确认依赖色谱与质谱的组合。反相高效液相色谱在 214 nm 紫外检测下分离主峰与相关杂质，给出纯度百分比与保留时间；电喷雾或基质辅助激光解吸电离质谱提供分子量，用于确认 N 端修饰是否完整。序列层面可通过肽图或氨基酸分析验证。含量测定常用紫外吸收法或氮元素分析，不同方法之间需要做交叉校验。
冻干粉末一般在 -20°C 或更低温度、干燥避光条件下保存，可维持较长时间的稳定。复溶后稳定性明显下降，溶液中的肽链易发生水解、氧化与聚集，通常需冷藏并在短期内用完。反复冻融会加速聚集与降解，建议分装后单次使用。缓冲体系的 pH 与离子强度同样影响聚集速率，需要按具体实验条件验证。
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
==== 2025 ==== Starting in January 2025, WWE began a partnership with Netflix where Raw would broadcast live worldwide weekly. Internationally outside the United States, all episodes of SmackDown and NXT, as well as livestreaming supercards, would also move to Netflix. With this partnership, WWE discontinued the WWE Network in all countries, with the exception of a few due to pre-existing contracts; by April 1, 2026, all other countries had transitioned to Netflix, bringing a complete end to the WWE Network, with the exception of Sub-Saharan Africa and Japan, which remain on SuperSport and Abema, respectively. Every livestreaming supercard in 2025 would air on Peacock in the United States until August 2025, after which, they transferred to ESPN. With the discontinuation of the WWE Network around the world, the "Network exclusive" notation is no longer valid as of January 2025.
== History == The company was founded in 1922 in Bern as a cooperative at the instigation of the chemist Oscar Bally-Forcart and initially produced pharmaceuticals for the Haaf pharmacy in Bern. As early as 1923 it was converted into a joint-stock company (Aktiengesellschaft), whose shareholders came mainly from Basel financial circles, with its production site at Gümligen. Since 1929 the firm has worked with Migros, which, as a major customer, sells Haco products under its own brand. In 1965 the company gave up pharmaceutical research, which the future Nobel laureate Tadeusz Reichstein had led to great success. In 1979 Narida AG was founded in Schwarzenburg; it was brought together with Haco under the umbrella of Haco Holding AG, Gümligen. In 2005 the company opened a new production plant in Malaysia to serve its export markets in Asia and North America. Among Haco's significant innovations were the production of a decaffeinated coffee without harmful residues (1930), the synthesis of vitamin C (1931), the development of cortin and cortisone, the production of soluble coffee (1938) and freeze-dried coffee (1969), the decaffeination of tea (1979), and the production of cereal bars and the freeze-drying of tea extracts (1994). In 2005 the company, owned by about 160 shareholders, most of them descendants of the founding families, had about 550 employees.
Righthanded β-helices, typified by the pectate lyase enzyme shown at left or P22 phage tailspike protein, have a less regular cross-section, longer and indented on one of the sides; of the three linker loops, one is consistently just two residues long and the others are variable, often elaborated to form a binding or active site. A two-sided β-helix (right-handed) is found in some bacterial metalloproteases; its two loops are each six residues long and bind stabilizing calcium ions to maintain the integrity of the structure, using the backbone and the Asp side chain oxygens of a GGXGXD sequence motif. This fold is called a β-roll in the SCOP classification.
Sources: en.wikipedia.org
== Mechanism of action == Abatacept is a soluble CTLA-4 analog that prevents antigen-presenting cells (APCs) from delivering the co-stimulatory signal. This prevents the T cells from being fully activated, and even downregulates them. Simple signaling without co-stimulation allows the cell to recognize the primary signal as "self" and not ramp-up responses for future responses as well. In order for T cells to be activated and attack an antigen, that antigen must be presented to the T cell by an APC. That activation requires two signals (one of which is called co-stimulatory signal or signal 2): For signal 1, the APC must bind the antigen to a major histocompatibility complex (MHC) molecule, bring that complex to its surface, and present it to the T cell receptor on the surface of the T cell. For signal 2, the APC must present a B7 protein (CD80 or CD86) on its cell surface to a CD28 protein on the surface of the T cell. These two signals activate the T cell. Without signal 2, the T cell will not be activated, and will become anergic. Abatacept, which consists of a fusion protein of the extracellular domain of CTLA-4 and human IgG1, binds to the B7 protein on the APC and prevents it from delivering the co-stimulatory signal to the T cell.
"I believe that all the power of the supreme being is not enough to liberate that despicable country (Peru): only Bolívar, supported by force, can do it." It is also known that San Martín wanted the disputed territory of Upper Peru, administered since 1810 by the Viceroyalty of Peru, to be handed over to the United Provinces of the Río de la Plata, which, although it would be somewhat predictable on his part (because it was an Argentine) in the exercise of a realpolitik, on the other hand it would be a sign of anti-Peruvianism on his part in the face of vague promises that he made to warlords, like Andrés de Santa Cruz, over the territory. Given this, he was allegedly accused of being dishonest with his ambiguous promises that he gave to Peruvian politicians who supported his government, since the Protectorate of San Martín de facto controlled the Atacama Party and was also claiming part of the territories of the current La Paz and Pando. That ended up generating a climate of mistrust, where the praises and praise of the Peruvians to the Liberator would have been apparent, in the midst of hostilities towards the Argentine caudillo. In the secret session of the Peruvian Congress, on September 27, 1822, suspicion and fear were expressed that San Martín tried to seize the provinces of Upper Peru, Arequipa and Cuzco.
==== Documentaries ==== The BBC interviewed Jung for Face to Face with John Freeman at Jung's home in Zurich in 1959. Stephen Segaller produced a documentary on Jung as part of his "World of Dreams", Wisdom of the Dream in 1985. It was re-issued in 2018. It was followed by a book of the same title. Matter of Heart (1986) is a documentary about Jung featuring interviews with those who knew him and archival footage. On 2 December 2004, BBC Radio 4's In Our Time broadcast a program on "the mind and theories" of Jung.
Sources: en.wikipedia.org
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.
It binds the growth hormone-releasing hormone receptor on anterior pituitary cells. Activation of that receptor promotes synthesis and release of growth hormone. The effect propagates through the growth hormone and insulin-like growth factor 1 axis.
Native GHRH is cleared quickly by peptidases, which limits how long it can stimulate its receptor. The added group hinders one of the primary cleavage enzymes. The practical consequence is a longer period of receptor activity per dose.
Reconstituted solutions are kept cold and used within the period stated on the label or certificate. Repeated warming and cooling cycles should be avoided because they encourage aggregation and gradual loss of potency.